Clin2
NCT04343365Possibly a fitRecruiting

Using tumor evolution to guide treatment choices

Incurable Disease

Part of Cancer clinical trials.

This trial uses information from your tumor’s changes over time to help your care team suggest treatment options. It may help people who are unlikely to be cured with standard treatment by testing new, personalized strategy plans.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
35 people
Ages
Any age
Study type
Observational

Who can take part

  • Your doctor believes your cancer is unlikely to be cured with usual treatment
  • You are expected to live at least 3 months
  • You can do most daily activities (ECOG 0 to 2)
  • You and your main oncologist are willing to consider the study’s recommended treatment strategies
  • You agree to return for follow-up visits, scans, and repeated blood tests over time

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06409390Recruiting· Phase 2
Sequential therapy based on tumor evolution for breast cancer

This trial tests a sequence of different treatments for breast cancer that has spread, based on how the cancer evolves. The goal is to find a personalized treatment plan that may work better over time.

Tampa, Florida
NCT06423950Recruiting
Expert tumor board for hard-to-treat childhood cancers

This study brings together a team of experts to review your case and suggest personalized treatment options. It's for children and young adults with cancers that are hard to cure, even with standard treatments, to find new ways to treat them.

Hartford, Connecticut
NCT05405413Recruiting· Phase 2
Personalized cancer treatment plan guided by tumor gene results

This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.

Lebanon, New Hampshire
NCT03503149Recruiting
Cancer patients get personalized tumor test guidance

This trial sets up a “molecular tumor board,” a team that reviews your tumor’s lab results and helps your doctor choose treatment options. It may help by making sense of tumor test findings so decisions are more personalized.

Tübingen, Baden-Wurttemberg
NCT07226180Enrolling by invitation
Building models from your tumor to guide treatment

This trial takes a small sample of your tumor to grow a model in the lab. This model helps doctors test which treatments might work best for you.

Irvine, California
NCT03089554Recruiting· Phase 2
Genetic tumor testing to guide targeted cancer treatments

This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.

Lexington, Kentucky

Hear when a new Incurable Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.